Journal of Advanced Research-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1213839, encodeId=3b2d121383901, content=想投，不知道今年****突破10后的接收率和审稿速度怎么样，欢迎分享经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=313c2584143, createdName=qianpingerke, createdTime=Sun Apr 24 09:40:08 CST 2022, time=2022-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2197764, encodeId=495d219e764c1, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：细胞生物学;急危重病 经验分享：2024.2.2投稿 技术审查10天 with editor 3天 2024.3.12审稿结束（3位审稿人，文章评价较高，意见较好，但仍然给了大修，时间21天） 2024.3.26修回 2024.4.7接收 感觉没有大家说的那么不负责任，应该是现在杂志水平高了就更专业了一些吧。整体来说是比较不错的，就是需要在投稿前准备完整的3份WB数据，并且一定要按照杂志要求的格式去准备手稿，感觉很多人技术审查很久是因为格式不符合。审稿人的意见也很细致，综合来看是不错的杂志，希望稳住一区，越来越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e018241697, createdName=ms2000000076814193, createdTime=Wed Apr 10 15:32:23 CST 2024, time=2024-04-10, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2175953, encodeId=94f221e59537e, content=11月23号投稿，然后一直是“有待技术评估”到12月16号让改格式、降重，19号改完返回, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/e8b5235f7abb4bcf90f5b2245264c95a-jim6YUjGO9EG.jpg, createdBy=cb276420537, createdName=ms5000000738743687, createdTime=Tue Dec 19 20:18:33 CST 2023, time=2023-12-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2159888, encodeId=3d7d2159888a4, content=偏重的研究方向：癌症 经验分享：Remove authors' names, affiliations and the corresponding author from the title page without authors' details. 投出去后，编辑要求修改，请问各位大佬，这个是什么意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJLPiafPkfZZg8HlzPIrlL0SViclianYmImK2NBiarA0kLrJl9pAFGnkwf5gJjvpetVSGR3IoAYMmdIZA/132, createdBy=ff4a2174656, createdName=起名字太麻烦了, createdTime=Tue Sep 26 21:25:42 CST 2023, time=2023-09-26, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1228665, encodeId=3e4a1228665e0, content=请问大家综述查重率控制在多少啊哭了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2fd6411974, createdName=ms1000001898370861, createdTime=Sat Jun 25 22:43:23 CST 2022, time=2022-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236219, encodeId=39b9123621925, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：垃圾期刊，质控很久，让调整格式重新提交，然后重新到主编手里，过了整整两个月。写着外审，一个月后回来一个审稿人的一小段话，里面写着一句跟楼上一位兄弟一样的评论：文章配不上这么高影响因子的期刊。感觉来来回回就是主编在送自己审或者熟人审，流程极慢，审一个月的审稿意见也没有实质性帮助，几句套话而已，垃圾。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bce31921883, createdName=zhengshq3, createdTime=Tue Aug 02 21:35:55 CST 2022, time=2022-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076609, encodeId=cbb910e660952, content=请问这个杂志每个作者都要同意才能进行下一步吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72e45450678, createdName=ms7000000699863453, createdTime=Fri Dec 03 17:42:14 CST 2021, time=2021-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082460, encodeId=dee6108246001, content=可惜没进1区, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3d0b1654103, createdName=wy-liang, createdTime=Tue Dec 21 09:22:34 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860298, encodeId=6b3c86029816, content=文章内容为药用真菌多组学研究。杂志更注重文章内容的新颖性。编辑非常负责，审稿周期短。小修后一般审稿人满意后一两周内就能online。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608b5414057, createdName=ms7657656453231030, createdTime=Thu May 07 14:44:55 CST 2020, time=2020-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2194212, encodeId=014c219421201, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：药物化学 经验分享：很难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffe79222552, createdName=ms8000000136394924, createdTime=Wed Mar 20 09:19:38 CST 2024, time=2024-03-20, status=1, ipAttribution=湖南省)]

2022-04-24 qianpingerke

想投，不知道今年****突破10后的接收率和审稿速度怎么样，欢迎分享经验

32 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1213839, encodeId=3b2d121383901, content=想投，不知道今年****突破10后的接收率和审稿速度怎么样，欢迎分享经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=313c2584143, createdName=qianpingerke, createdTime=Sun Apr 24 09:40:08 CST 2022, time=2022-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2197764, encodeId=495d219e764c1, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：细胞生物学;急危重病 经验分享：2024.2.2投稿 技术审查10天 with editor 3天 2024.3.12审稿结束（3位审稿人，文章评价较高，意见较好，但仍然给了大修，时间21天） 2024.3.26修回 2024.4.7接收 感觉没有大家说的那么不负责任，应该是现在杂志水平高了就更专业了一些吧。整体来说是比较不错的，就是需要在投稿前准备完整的3份WB数据，并且一定要按照杂志要求的格式去准备手稿，感觉很多人技术审查很久是因为格式不符合。审稿人的意见也很细致，综合来看是不错的杂志，希望稳住一区，越来越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e018241697, createdName=ms2000000076814193, createdTime=Wed Apr 10 15:32:23 CST 2024, time=2024-04-10, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2175953, encodeId=94f221e59537e, content=11月23号投稿，然后一直是“有待技术评估”到12月16号让改格式、降重，19号改完返回, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/e8b5235f7abb4bcf90f5b2245264c95a-jim6YUjGO9EG.jpg, createdBy=cb276420537, createdName=ms5000000738743687, createdTime=Tue Dec 19 20:18:33 CST 2023, time=2023-12-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2159888, encodeId=3d7d2159888a4, content=偏重的研究方向：癌症 经验分享：Remove authors' names, affiliations and the corresponding author from the title page without authors' details. 投出去后，编辑要求修改，请问各位大佬，这个是什么意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJLPiafPkfZZg8HlzPIrlL0SViclianYmImK2NBiarA0kLrJl9pAFGnkwf5gJjvpetVSGR3IoAYMmdIZA/132, createdBy=ff4a2174656, createdName=起名字太麻烦了, createdTime=Tue Sep 26 21:25:42 CST 2023, time=2023-09-26, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1228665, encodeId=3e4a1228665e0, content=请问大家综述查重率控制在多少啊哭了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2fd6411974, createdName=ms1000001898370861, createdTime=Sat Jun 25 22:43:23 CST 2022, time=2022-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236219, encodeId=39b9123621925, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：垃圾期刊，质控很久，让调整格式重新提交，然后重新到主编手里，过了整整两个月。写着外审，一个月后回来一个审稿人的一小段话，里面写着一句跟楼上一位兄弟一样的评论：文章配不上这么高影响因子的期刊。感觉来来回回就是主编在送自己审或者熟人审，流程极慢，审一个月的审稿意见也没有实质性帮助，几句套话而已，垃圾。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bce31921883, createdName=zhengshq3, createdTime=Tue Aug 02 21:35:55 CST 2022, time=2022-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076609, encodeId=cbb910e660952, content=请问这个杂志每个作者都要同意才能进行下一步吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72e45450678, createdName=ms7000000699863453, createdTime=Fri Dec 03 17:42:14 CST 2021, time=2021-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082460, encodeId=dee6108246001, content=可惜没进1区, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3d0b1654103, createdName=wy-liang, createdTime=Tue Dec 21 09:22:34 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860298, encodeId=6b3c86029816, content=文章内容为药用真菌多组学研究。杂志更注重文章内容的新颖性。编辑非常负责，审稿周期短。小修后一般审稿人满意后一两周内就能online。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608b5414057, createdName=ms7657656453231030, createdTime=Thu May 07 14:44:55 CST 2020, time=2020-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2194212, encodeId=014c219421201, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：药物化学 经验分享：很难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffe79222552, createdName=ms8000000136394924, createdTime=Wed Mar 20 09:19:38 CST 2024, time=2024-03-20, status=1, ipAttribution=湖南省)]

2024-04-10 ms2000000076814193 来自浙江省

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：细胞生物学;急危重病
经验分享：2024.2.2投稿
技术审查10天
with editor 3天
2024.3.12审稿结束（3位审稿人，文章评价较高，意见较好，但仍然给了大修，时间21天）
2024.3.26修回
2024.4.7接收

感觉没有大家说的那么不负责任，应该是现在杂志水平高了就更专业了一些吧。整体来说是比较不错的，就是需要在投稿前准备完整的3份WB数据，并且一定要按照杂志要求的格式去准备手稿，感觉很多人技术审查很久是因为格式不符合。审稿人的意见也很细致，综合来看是不错的杂志，希望稳住一区，越来越好。

14 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1213839, encodeId=3b2d121383901, content=想投，不知道今年****突破10后的接收率和审稿速度怎么样，欢迎分享经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=313c2584143, createdName=qianpingerke, createdTime=Sun Apr 24 09:40:08 CST 2022, time=2022-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2197764, encodeId=495d219e764c1, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：细胞生物学;急危重病 经验分享：2024.2.2投稿 技术审查10天 with editor 3天 2024.3.12审稿结束（3位审稿人，文章评价较高，意见较好，但仍然给了大修，时间21天） 2024.3.26修回 2024.4.7接收 感觉没有大家说的那么不负责任，应该是现在杂志水平高了就更专业了一些吧。整体来说是比较不错的，就是需要在投稿前准备完整的3份WB数据，并且一定要按照杂志要求的格式去准备手稿，感觉很多人技术审查很久是因为格式不符合。审稿人的意见也很细致，综合来看是不错的杂志，希望稳住一区，越来越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e018241697, createdName=ms2000000076814193, createdTime=Wed Apr 10 15:32:23 CST 2024, time=2024-04-10, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2175953, encodeId=94f221e59537e, content=11月23号投稿，然后一直是“有待技术评估”到12月16号让改格式、降重，19号改完返回, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/e8b5235f7abb4bcf90f5b2245264c95a-jim6YUjGO9EG.jpg, createdBy=cb276420537, createdName=ms5000000738743687, createdTime=Tue Dec 19 20:18:33 CST 2023, time=2023-12-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2159888, encodeId=3d7d2159888a4, content=偏重的研究方向：癌症 经验分享：Remove authors' names, affiliations and the corresponding author from the title page without authors' details. 投出去后，编辑要求修改，请问各位大佬，这个是什么意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJLPiafPkfZZg8HlzPIrlL0SViclianYmImK2NBiarA0kLrJl9pAFGnkwf5gJjvpetVSGR3IoAYMmdIZA/132, createdBy=ff4a2174656, createdName=起名字太麻烦了, createdTime=Tue Sep 26 21:25:42 CST 2023, time=2023-09-26, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1228665, encodeId=3e4a1228665e0, content=请问大家综述查重率控制在多少啊哭了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2fd6411974, createdName=ms1000001898370861, createdTime=Sat Jun 25 22:43:23 CST 2022, time=2022-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236219, encodeId=39b9123621925, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：垃圾期刊，质控很久，让调整格式重新提交，然后重新到主编手里，过了整整两个月。写着外审，一个月后回来一个审稿人的一小段话，里面写着一句跟楼上一位兄弟一样的评论：文章配不上这么高影响因子的期刊。感觉来来回回就是主编在送自己审或者熟人审，流程极慢，审一个月的审稿意见也没有实质性帮助，几句套话而已，垃圾。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bce31921883, createdName=zhengshq3, createdTime=Tue Aug 02 21:35:55 CST 2022, time=2022-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076609, encodeId=cbb910e660952, content=请问这个杂志每个作者都要同意才能进行下一步吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72e45450678, createdName=ms7000000699863453, createdTime=Fri Dec 03 17:42:14 CST 2021, time=2021-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082460, encodeId=dee6108246001, content=可惜没进1区, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3d0b1654103, createdName=wy-liang, createdTime=Tue Dec 21 09:22:34 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860298, encodeId=6b3c86029816, content=文章内容为药用真菌多组学研究。杂志更注重文章内容的新颖性。编辑非常负责，审稿周期短。小修后一般审稿人满意后一两周内就能online。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608b5414057, createdName=ms7657656453231030, createdTime=Thu May 07 14:44:55 CST 2020, time=2020-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2194212, encodeId=014c219421201, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：药物化学 经验分享：很难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffe79222552, createdName=ms8000000136394924, createdTime=Wed Mar 20 09:19:38 CST 2024, time=2024-03-20, status=1, ipAttribution=湖南省)]

2023-12-19 ms5000000738743687 来自江苏省

11月23号投稿，然后一直是“有待技术评估”到12月16号让改格式、降重，19号改完返回

88 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1213839, encodeId=3b2d121383901, content=想投，不知道今年****突破10后的接收率和审稿速度怎么样，欢迎分享经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=313c2584143, createdName=qianpingerke, createdTime=Sun Apr 24 09:40:08 CST 2022, time=2022-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2197764, encodeId=495d219e764c1, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：细胞生物学;急危重病 经验分享：2024.2.2投稿 技术审查10天 with editor 3天 2024.3.12审稿结束（3位审稿人，文章评价较高，意见较好，但仍然给了大修，时间21天） 2024.3.26修回 2024.4.7接收 感觉没有大家说的那么不负责任，应该是现在杂志水平高了就更专业了一些吧。整体来说是比较不错的，就是需要在投稿前准备完整的3份WB数据，并且一定要按照杂志要求的格式去准备手稿，感觉很多人技术审查很久是因为格式不符合。审稿人的意见也很细致，综合来看是不错的杂志，希望稳住一区，越来越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e018241697, createdName=ms2000000076814193, createdTime=Wed Apr 10 15:32:23 CST 2024, time=2024-04-10, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2175953, encodeId=94f221e59537e, content=11月23号投稿，然后一直是“有待技术评估”到12月16号让改格式、降重，19号改完返回, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/e8b5235f7abb4bcf90f5b2245264c95a-jim6YUjGO9EG.jpg, createdBy=cb276420537, createdName=ms5000000738743687, createdTime=Tue Dec 19 20:18:33 CST 2023, time=2023-12-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2159888, encodeId=3d7d2159888a4, content=偏重的研究方向：癌症 经验分享：Remove authors' names, affiliations and the corresponding author from the title page without authors' details. 投出去后，编辑要求修改，请问各位大佬，这个是什么意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJLPiafPkfZZg8HlzPIrlL0SViclianYmImK2NBiarA0kLrJl9pAFGnkwf5gJjvpetVSGR3IoAYMmdIZA/132, createdBy=ff4a2174656, createdName=起名字太麻烦了, createdTime=Tue Sep 26 21:25:42 CST 2023, time=2023-09-26, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1228665, encodeId=3e4a1228665e0, content=请问大家综述查重率控制在多少啊哭了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2fd6411974, createdName=ms1000001898370861, createdTime=Sat Jun 25 22:43:23 CST 2022, time=2022-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236219, encodeId=39b9123621925, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：垃圾期刊，质控很久，让调整格式重新提交，然后重新到主编手里，过了整整两个月。写着外审，一个月后回来一个审稿人的一小段话，里面写着一句跟楼上一位兄弟一样的评论：文章配不上这么高影响因子的期刊。感觉来来回回就是主编在送自己审或者熟人审，流程极慢，审一个月的审稿意见也没有实质性帮助，几句套话而已，垃圾。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bce31921883, createdName=zhengshq3, createdTime=Tue Aug 02 21:35:55 CST 2022, time=2022-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076609, encodeId=cbb910e660952, content=请问这个杂志每个作者都要同意才能进行下一步吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72e45450678, createdName=ms7000000699863453, createdTime=Fri Dec 03 17:42:14 CST 2021, time=2021-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082460, encodeId=dee6108246001, content=可惜没进1区, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3d0b1654103, createdName=wy-liang, createdTime=Tue Dec 21 09:22:34 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860298, encodeId=6b3c86029816, content=文章内容为药用真菌多组学研究。杂志更注重文章内容的新颖性。编辑非常负责，审稿周期短。小修后一般审稿人满意后一两周内就能online。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608b5414057, createdName=ms7657656453231030, createdTime=Thu May 07 14:44:55 CST 2020, time=2020-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2194212, encodeId=014c219421201, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：药物化学 经验分享：很难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffe79222552, createdName=ms8000000136394924, createdTime=Wed Mar 20 09:19:38 CST 2024, time=2024-03-20, status=1, ipAttribution=湖南省)]

2023-09-26 起名字太麻烦了来自广东省

偏重的研究方向：癌症
经验分享：Remove authors' names, affiliations and the corresponding author from the title page without authors' details. 投出去后，编辑要求修改，请问各位大佬，这个是什么意思

34 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1213839, encodeId=3b2d121383901, content=想投，不知道今年****突破10后的接收率和审稿速度怎么样，欢迎分享经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=313c2584143, createdName=qianpingerke, createdTime=Sun Apr 24 09:40:08 CST 2022, time=2022-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2197764, encodeId=495d219e764c1, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：细胞生物学;急危重病 经验分享：2024.2.2投稿 技术审查10天 with editor 3天 2024.3.12审稿结束（3位审稿人，文章评价较高，意见较好，但仍然给了大修，时间21天） 2024.3.26修回 2024.4.7接收 感觉没有大家说的那么不负责任，应该是现在杂志水平高了就更专业了一些吧。整体来说是比较不错的，就是需要在投稿前准备完整的3份WB数据，并且一定要按照杂志要求的格式去准备手稿，感觉很多人技术审查很久是因为格式不符合。审稿人的意见也很细致，综合来看是不错的杂志，希望稳住一区，越来越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e018241697, createdName=ms2000000076814193, createdTime=Wed Apr 10 15:32:23 CST 2024, time=2024-04-10, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2175953, encodeId=94f221e59537e, content=11月23号投稿，然后一直是“有待技术评估”到12月16号让改格式、降重，19号改完返回, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/e8b5235f7abb4bcf90f5b2245264c95a-jim6YUjGO9EG.jpg, createdBy=cb276420537, createdName=ms5000000738743687, createdTime=Tue Dec 19 20:18:33 CST 2023, time=2023-12-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2159888, encodeId=3d7d2159888a4, content=偏重的研究方向：癌症 经验分享：Remove authors' names, affiliations and the corresponding author from the title page without authors' details. 投出去后，编辑要求修改，请问各位大佬，这个是什么意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJLPiafPkfZZg8HlzPIrlL0SViclianYmImK2NBiarA0kLrJl9pAFGnkwf5gJjvpetVSGR3IoAYMmdIZA/132, createdBy=ff4a2174656, createdName=起名字太麻烦了, createdTime=Tue Sep 26 21:25:42 CST 2023, time=2023-09-26, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1228665, encodeId=3e4a1228665e0, content=请问大家综述查重率控制在多少啊哭了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2fd6411974, createdName=ms1000001898370861, createdTime=Sat Jun 25 22:43:23 CST 2022, time=2022-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236219, encodeId=39b9123621925, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：垃圾期刊，质控很久，让调整格式重新提交，然后重新到主编手里，过了整整两个月。写着外审，一个月后回来一个审稿人的一小段话，里面写着一句跟楼上一位兄弟一样的评论：文章配不上这么高影响因子的期刊。感觉来来回回就是主编在送自己审或者熟人审，流程极慢，审一个月的审稿意见也没有实质性帮助，几句套话而已，垃圾。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bce31921883, createdName=zhengshq3, createdTime=Tue Aug 02 21:35:55 CST 2022, time=2022-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076609, encodeId=cbb910e660952, content=请问这个杂志每个作者都要同意才能进行下一步吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72e45450678, createdName=ms7000000699863453, createdTime=Fri Dec 03 17:42:14 CST 2021, time=2021-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082460, encodeId=dee6108246001, content=可惜没进1区, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3d0b1654103, createdName=wy-liang, createdTime=Tue Dec 21 09:22:34 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860298, encodeId=6b3c86029816, content=文章内容为药用真菌多组学研究。杂志更注重文章内容的新颖性。编辑非常负责，审稿周期短。小修后一般审稿人满意后一两周内就能online。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608b5414057, createdName=ms7657656453231030, createdTime=Thu May 07 14:44:55 CST 2020, time=2020-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2194212, encodeId=014c219421201, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：药物化学 经验分享：很难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffe79222552, createdName=ms8000000136394924, createdTime=Wed Mar 20 09:19:38 CST 2024, time=2024-03-20, status=1, ipAttribution=湖南省)]

2022-06-25 ms1000001898370861

请问大家综述查重率控制在多少啊哭了

108 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1213839, encodeId=3b2d121383901, content=想投，不知道今年****突破10后的接收率和审稿速度怎么样，欢迎分享经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=313c2584143, createdName=qianpingerke, createdTime=Sun Apr 24 09:40:08 CST 2022, time=2022-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2197764, encodeId=495d219e764c1, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：细胞生物学;急危重病 经验分享：2024.2.2投稿 技术审查10天 with editor 3天 2024.3.12审稿结束（3位审稿人，文章评价较高，意见较好，但仍然给了大修，时间21天） 2024.3.26修回 2024.4.7接收 感觉没有大家说的那么不负责任，应该是现在杂志水平高了就更专业了一些吧。整体来说是比较不错的，就是需要在投稿前准备完整的3份WB数据，并且一定要按照杂志要求的格式去准备手稿，感觉很多人技术审查很久是因为格式不符合。审稿人的意见也很细致，综合来看是不错的杂志，希望稳住一区，越来越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e018241697, createdName=ms2000000076814193, createdTime=Wed Apr 10 15:32:23 CST 2024, time=2024-04-10, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2175953, encodeId=94f221e59537e, content=11月23号投稿，然后一直是“有待技术评估”到12月16号让改格式、降重，19号改完返回, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/e8b5235f7abb4bcf90f5b2245264c95a-jim6YUjGO9EG.jpg, createdBy=cb276420537, createdName=ms5000000738743687, createdTime=Tue Dec 19 20:18:33 CST 2023, time=2023-12-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2159888, encodeId=3d7d2159888a4, content=偏重的研究方向：癌症 经验分享：Remove authors' names, affiliations and the corresponding author from the title page without authors' details. 投出去后，编辑要求修改，请问各位大佬，这个是什么意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJLPiafPkfZZg8HlzPIrlL0SViclianYmImK2NBiarA0kLrJl9pAFGnkwf5gJjvpetVSGR3IoAYMmdIZA/132, createdBy=ff4a2174656, createdName=起名字太麻烦了, createdTime=Tue Sep 26 21:25:42 CST 2023, time=2023-09-26, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1228665, encodeId=3e4a1228665e0, content=请问大家综述查重率控制在多少啊哭了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2fd6411974, createdName=ms1000001898370861, createdTime=Sat Jun 25 22:43:23 CST 2022, time=2022-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236219, encodeId=39b9123621925, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：垃圾期刊，质控很久，让调整格式重新提交，然后重新到主编手里，过了整整两个月。写着外审，一个月后回来一个审稿人的一小段话，里面写着一句跟楼上一位兄弟一样的评论：文章配不上这么高影响因子的期刊。感觉来来回回就是主编在送自己审或者熟人审，流程极慢，审一个月的审稿意见也没有实质性帮助，几句套话而已，垃圾。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bce31921883, createdName=zhengshq3, createdTime=Tue Aug 02 21:35:55 CST 2022, time=2022-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076609, encodeId=cbb910e660952, content=请问这个杂志每个作者都要同意才能进行下一步吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72e45450678, createdName=ms7000000699863453, createdTime=Fri Dec 03 17:42:14 CST 2021, time=2021-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082460, encodeId=dee6108246001, content=可惜没进1区, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3d0b1654103, createdName=wy-liang, createdTime=Tue Dec 21 09:22:34 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860298, encodeId=6b3c86029816, content=文章内容为药用真菌多组学研究。杂志更注重文章内容的新颖性。编辑非常负责，审稿周期短。小修后一般审稿人满意后一两周内就能online。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608b5414057, createdName=ms7657656453231030, createdTime=Thu May 07 14:44:55 CST 2020, time=2020-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2194212, encodeId=014c219421201, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：药物化学 经验分享：很难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffe79222552, createdName=ms8000000136394924, createdTime=Wed Mar 20 09:19:38 CST 2024, time=2024-03-20, status=1, ipAttribution=湖南省)]

2022-08-02 zhengshq3

审稿速度:6.0 | 投稿命中率:5.0
经验分享：垃圾期刊，质控很久，让调整格式重新提交，然后重新到主编手里，过了整整两个月。写着外审，一个月后回来一个审稿人的一小段话，里面写着一句跟楼上一位兄弟一样的评论：文章配不上这么高影响因子的期刊。感觉来来回回就是主编在送自己审或者熟人审，流程极慢，审一个月的审稿意见也没有实质性帮助，几句套话而已，垃圾。

126 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1213839, encodeId=3b2d121383901, content=想投，不知道今年****突破10后的接收率和审稿速度怎么样，欢迎分享经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=313c2584143, createdName=qianpingerke, createdTime=Sun Apr 24 09:40:08 CST 2022, time=2022-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2197764, encodeId=495d219e764c1, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：细胞生物学;急危重病 经验分享：2024.2.2投稿 技术审查10天 with editor 3天 2024.3.12审稿结束（3位审稿人，文章评价较高，意见较好，但仍然给了大修，时间21天） 2024.3.26修回 2024.4.7接收 感觉没有大家说的那么不负责任，应该是现在杂志水平高了就更专业了一些吧。整体来说是比较不错的，就是需要在投稿前准备完整的3份WB数据，并且一定要按照杂志要求的格式去准备手稿，感觉很多人技术审查很久是因为格式不符合。审稿人的意见也很细致，综合来看是不错的杂志，希望稳住一区，越来越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e018241697, createdName=ms2000000076814193, createdTime=Wed Apr 10 15:32:23 CST 2024, time=2024-04-10, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2175953, encodeId=94f221e59537e, content=11月23号投稿，然后一直是“有待技术评估”到12月16号让改格式、降重，19号改完返回, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/e8b5235f7abb4bcf90f5b2245264c95a-jim6YUjGO9EG.jpg, createdBy=cb276420537, createdName=ms5000000738743687, createdTime=Tue Dec 19 20:18:33 CST 2023, time=2023-12-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2159888, encodeId=3d7d2159888a4, content=偏重的研究方向：癌症 经验分享：Remove authors' names, affiliations and the corresponding author from the title page without authors' details. 投出去后，编辑要求修改，请问各位大佬，这个是什么意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJLPiafPkfZZg8HlzPIrlL0SViclianYmImK2NBiarA0kLrJl9pAFGnkwf5gJjvpetVSGR3IoAYMmdIZA/132, createdBy=ff4a2174656, createdName=起名字太麻烦了, createdTime=Tue Sep 26 21:25:42 CST 2023, time=2023-09-26, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1228665, encodeId=3e4a1228665e0, content=请问大家综述查重率控制在多少啊哭了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2fd6411974, createdName=ms1000001898370861, createdTime=Sat Jun 25 22:43:23 CST 2022, time=2022-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236219, encodeId=39b9123621925, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：垃圾期刊，质控很久，让调整格式重新提交，然后重新到主编手里，过了整整两个月。写着外审，一个月后回来一个审稿人的一小段话，里面写着一句跟楼上一位兄弟一样的评论：文章配不上这么高影响因子的期刊。感觉来来回回就是主编在送自己审或者熟人审，流程极慢，审一个月的审稿意见也没有实质性帮助，几句套话而已，垃圾。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bce31921883, createdName=zhengshq3, createdTime=Tue Aug 02 21:35:55 CST 2022, time=2022-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076609, encodeId=cbb910e660952, content=请问这个杂志每个作者都要同意才能进行下一步吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72e45450678, createdName=ms7000000699863453, createdTime=Fri Dec 03 17:42:14 CST 2021, time=2021-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082460, encodeId=dee6108246001, content=可惜没进1区, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3d0b1654103, createdName=wy-liang, createdTime=Tue Dec 21 09:22:34 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860298, encodeId=6b3c86029816, content=文章内容为药用真菌多组学研究。杂志更注重文章内容的新颖性。编辑非常负责，审稿周期短。小修后一般审稿人满意后一两周内就能online。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608b5414057, createdName=ms7657656453231030, createdTime=Thu May 07 14:44:55 CST 2020, time=2020-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2194212, encodeId=014c219421201, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：药物化学 经验分享：很难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffe79222552, createdName=ms8000000136394924, createdTime=Wed Mar 20 09:19:38 CST 2024, time=2024-03-20, status=1, ipAttribution=湖南省)]

2021-12-03 ms7000000699863453

请问这个杂志每个作者都要同意才能进行下一步吗？

135 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1213839, encodeId=3b2d121383901, content=想投，不知道今年****突破10后的接收率和审稿速度怎么样，欢迎分享经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=313c2584143, createdName=qianpingerke, createdTime=Sun Apr 24 09:40:08 CST 2022, time=2022-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2197764, encodeId=495d219e764c1, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：细胞生物学;急危重病 经验分享：2024.2.2投稿 技术审查10天 with editor 3天 2024.3.12审稿结束（3位审稿人，文章评价较高，意见较好，但仍然给了大修，时间21天） 2024.3.26修回 2024.4.7接收 感觉没有大家说的那么不负责任，应该是现在杂志水平高了就更专业了一些吧。整体来说是比较不错的，就是需要在投稿前准备完整的3份WB数据，并且一定要按照杂志要求的格式去准备手稿，感觉很多人技术审查很久是因为格式不符合。审稿人的意见也很细致，综合来看是不错的杂志，希望稳住一区，越来越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e018241697, createdName=ms2000000076814193, createdTime=Wed Apr 10 15:32:23 CST 2024, time=2024-04-10, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2175953, encodeId=94f221e59537e, content=11月23号投稿，然后一直是“有待技术评估”到12月16号让改格式、降重，19号改完返回, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/e8b5235f7abb4bcf90f5b2245264c95a-jim6YUjGO9EG.jpg, createdBy=cb276420537, createdName=ms5000000738743687, createdTime=Tue Dec 19 20:18:33 CST 2023, time=2023-12-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2159888, encodeId=3d7d2159888a4, content=偏重的研究方向：癌症 经验分享：Remove authors' names, affiliations and the corresponding author from the title page without authors' details. 投出去后，编辑要求修改，请问各位大佬，这个是什么意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJLPiafPkfZZg8HlzPIrlL0SViclianYmImK2NBiarA0kLrJl9pAFGnkwf5gJjvpetVSGR3IoAYMmdIZA/132, createdBy=ff4a2174656, createdName=起名字太麻烦了, createdTime=Tue Sep 26 21:25:42 CST 2023, time=2023-09-26, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1228665, encodeId=3e4a1228665e0, content=请问大家综述查重率控制在多少啊哭了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2fd6411974, createdName=ms1000001898370861, createdTime=Sat Jun 25 22:43:23 CST 2022, time=2022-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236219, encodeId=39b9123621925, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：垃圾期刊，质控很久，让调整格式重新提交，然后重新到主编手里，过了整整两个月。写着外审，一个月后回来一个审稿人的一小段话，里面写着一句跟楼上一位兄弟一样的评论：文章配不上这么高影响因子的期刊。感觉来来回回就是主编在送自己审或者熟人审，流程极慢，审一个月的审稿意见也没有实质性帮助，几句套话而已，垃圾。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bce31921883, createdName=zhengshq3, createdTime=Tue Aug 02 21:35:55 CST 2022, time=2022-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076609, encodeId=cbb910e660952, content=请问这个杂志每个作者都要同意才能进行下一步吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72e45450678, createdName=ms7000000699863453, createdTime=Fri Dec 03 17:42:14 CST 2021, time=2021-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082460, encodeId=dee6108246001, content=可惜没进1区, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3d0b1654103, createdName=wy-liang, createdTime=Tue Dec 21 09:22:34 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860298, encodeId=6b3c86029816, content=文章内容为药用真菌多组学研究。杂志更注重文章内容的新颖性。编辑非常负责，审稿周期短。小修后一般审稿人满意后一两周内就能online。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608b5414057, createdName=ms7657656453231030, createdTime=Thu May 07 14:44:55 CST 2020, time=2020-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2194212, encodeId=014c219421201, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：药物化学 经验分享：很难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffe79222552, createdName=ms8000000136394924, createdTime=Wed Mar 20 09:19:38 CST 2024, time=2024-03-20, status=1, ipAttribution=湖南省)]

2021-12-21 wy-liang

可惜没进1区

39 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1213839, encodeId=3b2d121383901, content=想投，不知道今年****突破10后的接收率和审稿速度怎么样，欢迎分享经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=313c2584143, createdName=qianpingerke, createdTime=Sun Apr 24 09:40:08 CST 2022, time=2022-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2197764, encodeId=495d219e764c1, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：细胞生物学;急危重病 经验分享：2024.2.2投稿 技术审查10天 with editor 3天 2024.3.12审稿结束（3位审稿人，文章评价较高，意见较好，但仍然给了大修，时间21天） 2024.3.26修回 2024.4.7接收 感觉没有大家说的那么不负责任，应该是现在杂志水平高了就更专业了一些吧。整体来说是比较不错的，就是需要在投稿前准备完整的3份WB数据，并且一定要按照杂志要求的格式去准备手稿，感觉很多人技术审查很久是因为格式不符合。审稿人的意见也很细致，综合来看是不错的杂志，希望稳住一区，越来越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e018241697, createdName=ms2000000076814193, createdTime=Wed Apr 10 15:32:23 CST 2024, time=2024-04-10, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2175953, encodeId=94f221e59537e, content=11月23号投稿，然后一直是“有待技术评估”到12月16号让改格式、降重，19号改完返回, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/e8b5235f7abb4bcf90f5b2245264c95a-jim6YUjGO9EG.jpg, createdBy=cb276420537, createdName=ms5000000738743687, createdTime=Tue Dec 19 20:18:33 CST 2023, time=2023-12-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2159888, encodeId=3d7d2159888a4, content=偏重的研究方向：癌症 经验分享：Remove authors' names, affiliations and the corresponding author from the title page without authors' details. 投出去后，编辑要求修改，请问各位大佬，这个是什么意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJLPiafPkfZZg8HlzPIrlL0SViclianYmImK2NBiarA0kLrJl9pAFGnkwf5gJjvpetVSGR3IoAYMmdIZA/132, createdBy=ff4a2174656, createdName=起名字太麻烦了, createdTime=Tue Sep 26 21:25:42 CST 2023, time=2023-09-26, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1228665, encodeId=3e4a1228665e0, content=请问大家综述查重率控制在多少啊哭了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2fd6411974, createdName=ms1000001898370861, createdTime=Sat Jun 25 22:43:23 CST 2022, time=2022-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236219, encodeId=39b9123621925, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：垃圾期刊，质控很久，让调整格式重新提交，然后重新到主编手里，过了整整两个月。写着外审，一个月后回来一个审稿人的一小段话，里面写着一句跟楼上一位兄弟一样的评论：文章配不上这么高影响因子的期刊。感觉来来回回就是主编在送自己审或者熟人审，流程极慢，审一个月的审稿意见也没有实质性帮助，几句套话而已，垃圾。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bce31921883, createdName=zhengshq3, createdTime=Tue Aug 02 21:35:55 CST 2022, time=2022-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076609, encodeId=cbb910e660952, content=请问这个杂志每个作者都要同意才能进行下一步吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72e45450678, createdName=ms7000000699863453, createdTime=Fri Dec 03 17:42:14 CST 2021, time=2021-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082460, encodeId=dee6108246001, content=可惜没进1区, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3d0b1654103, createdName=wy-liang, createdTime=Tue Dec 21 09:22:34 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860298, encodeId=6b3c86029816, content=文章内容为药用真菌多组学研究。杂志更注重文章内容的新颖性。编辑非常负责，审稿周期短。小修后一般审稿人满意后一两周内就能online。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608b5414057, createdName=ms7657656453231030, createdTime=Thu May 07 14:44:55 CST 2020, time=2020-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2194212, encodeId=014c219421201, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：药物化学 经验分享：很难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffe79222552, createdName=ms8000000136394924, createdTime=Wed Mar 20 09:19:38 CST 2024, time=2024-03-20, status=1, ipAttribution=湖南省)]

2020-05-07 ms7657656453231030

文章内容为药用真菌多组学研究。杂志更注重文章内容的新颖性。编辑非常负责，审稿周期短。小修后一般审稿人满意后一两周内就能online。

68 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1213839, encodeId=3b2d121383901, content=想投，不知道今年****突破10后的接收率和审稿速度怎么样，欢迎分享经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=313c2584143, createdName=qianpingerke, createdTime=Sun Apr 24 09:40:08 CST 2022, time=2022-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2197764, encodeId=495d219e764c1, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：细胞生物学;急危重病 经验分享：2024.2.2投稿 技术审查10天 with editor 3天 2024.3.12审稿结束（3位审稿人，文章评价较高，意见较好，但仍然给了大修，时间21天） 2024.3.26修回 2024.4.7接收 感觉没有大家说的那么不负责任，应该是现在杂志水平高了就更专业了一些吧。整体来说是比较不错的，就是需要在投稿前准备完整的3份WB数据，并且一定要按照杂志要求的格式去准备手稿，感觉很多人技术审查很久是因为格式不符合。审稿人的意见也很细致，综合来看是不错的杂志，希望稳住一区，越来越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e018241697, createdName=ms2000000076814193, createdTime=Wed Apr 10 15:32:23 CST 2024, time=2024-04-10, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2175953, encodeId=94f221e59537e, content=11月23号投稿，然后一直是“有待技术评估”到12月16号让改格式、降重，19号改完返回, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/e8b5235f7abb4bcf90f5b2245264c95a-jim6YUjGO9EG.jpg, createdBy=cb276420537, createdName=ms5000000738743687, createdTime=Tue Dec 19 20:18:33 CST 2023, time=2023-12-19, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2159888, encodeId=3d7d2159888a4, content=偏重的研究方向：癌症 经验分享：Remove authors' names, affiliations and the corresponding author from the title page without authors' details. 投出去后，编辑要求修改，请问各位大佬，这个是什么意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJLPiafPkfZZg8HlzPIrlL0SViclianYmImK2NBiarA0kLrJl9pAFGnkwf5gJjvpetVSGR3IoAYMmdIZA/132, createdBy=ff4a2174656, createdName=起名字太麻烦了, createdTime=Tue Sep 26 21:25:42 CST 2023, time=2023-09-26, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1228665, encodeId=3e4a1228665e0, content=请问大家综述查重率控制在多少啊哭了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2fd6411974, createdName=ms1000001898370861, createdTime=Sat Jun 25 22:43:23 CST 2022, time=2022-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236219, encodeId=39b9123621925, content=审稿速度:6.0 | 投稿命中率:5.0 经验分享：垃圾期刊，质控很久，让调整格式重新提交，然后重新到主编手里，过了整整两个月。写着外审，一个月后回来一个审稿人的一小段话，里面写着一句跟楼上一位兄弟一样的评论：文章配不上这么高影响因子的期刊。感觉来来回回就是主编在送自己审或者熟人审，流程极慢，审一个月的审稿意见也没有实质性帮助，几句套话而已，垃圾。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bce31921883, createdName=zhengshq3, createdTime=Tue Aug 02 21:35:55 CST 2022, time=2022-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1076609, encodeId=cbb910e660952, content=请问这个杂志每个作者都要同意才能进行下一步吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72e45450678, createdName=ms7000000699863453, createdTime=Fri Dec 03 17:42:14 CST 2021, time=2021-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1082460, encodeId=dee6108246001, content=可惜没进1区, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3d0b1654103, createdName=wy-liang, createdTime=Tue Dec 21 09:22:34 CST 2021, time=2021-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860298, encodeId=6b3c86029816, content=文章内容为药用真菌多组学研究。杂志更注重文章内容的新颖性。编辑非常负责，审稿周期短。小修后一般审稿人满意后一两周内就能online。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=608b5414057, createdName=ms7657656453231030, createdTime=Thu May 07 14:44:55 CST 2020, time=2020-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2194212, encodeId=014c219421201, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：药物化学 经验分享：很难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ffe79222552, createdName=ms8000000136394924, createdTime=Wed Mar 20 09:19:38 CST 2024, time=2024-03-20, status=1, ipAttribution=湖南省)]

2024-03-20 ms8000000136394924 来自湖南省

审稿速度:2.0 | 投稿命中率:25.0
偏重的研究方向：药物化学
经验分享：很难

44 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务